FDA recall D-0502-2026
Wells Pharma of Houston LLC · Class II · drug
Product
Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 73702-122-03
Reason for recall
cGMP deviations.
Distribution
U.S. Nationwide.
Key facts
- Status
- Ongoing
- Initiation date
- 2026-04-01
- Report date
- 2026-05-06
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Houston, TX, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0502-2026